Ausgabe 4/2023
Inhalt (30 Artikel)
Sex-based differences in nuclear medicine imaging and therapy
Riemer H. J. A. Slart, Lioe-Fee de Geus-Oei, Jasper Stevens, Philip A. Elsinga, Oleksandra Ivashchenko, Paola A. Erba
Preoperative stratification of cytologically indeterminate thyroid nodules by [18F]FDG-PET: can Orpheus bring back Eurydice?
Dennis Vriens, Elizabeth J. de Koster, Lioe-Fee de Geus-Oei, Wim J. G. Oyen
EANM practice guideline for quantitative SPECT-CT
John C. Dickson, Ian S. Armstrong, Pablo Minguez Gabiña, Ana M. Denis-Bacelar, Aron K. Krizsan, Jonathan M. Gear, Tim Van den Wyngaert, Lioe-Fee de Geus-Oei, Ken Herrmann
Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)
Estel Collado Camps, Sanne A. M. van Lith, Annemarie Kip, Cathelijne Frielink, Lieke Joosten, Roland Brock, Martin Gotthardt
99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types
Betül Altunay, Andreas Goedicke, Oliver H. Winz, Fabian Hertel, Dirk von Mallek, Levente K. Meszaros, Gitasha Chand, Hans-Jürgen Biersack, Elmar Stickeler, Katja Krauss, Felix M. Mottaghy
Current research topics in FAPI theranostics: a bibliometric analysis
Andor F. van den Hoven, Ruth G. M. Keijsers, Marnix G. E. H. Lam, Andor W. J. M. Glaudemans, Frederik A. Verburg, Wouter V. Vogel, Jules Lavalaye
Multi-center, multi-vendor validation of deep learning-based attenuation correction in SPECT MPI: data from the international flurpiridaz-301 trial
Tomoe Hagio, Jonathan B. Moody, Alexis Poitrasson-Rivière, Jennifer M. Renaud, Lora Pierce, Christopher Buckley, Edward P. Ficaro, Venkatesh L. Murthy
Decentralized collaborative multi-institutional PET attenuation and scatter correction using federated deep learning
Isaac Shiri, Alireza Vafaei Sadr, Azadeh Akhavan, Yazdan Salimi, Amirhossein Sanaat, Mehdi Amini, Behrooz Razeghi, Abdollah Saberi, Hossein Arabi, Sohrab Ferdowsi, Slava Voloshynovskiy, Deniz Gündüz, Arman Rahmim, Habib Zaidi
In vivo methods for imaging blood–brain barrier function and dysfunction
William James Harris, Marie-Claude Asselin, Rainer Hinz, Laura Michelle Parkes, Stuart Allan, Ingo Schiessl, Herve Boutin, Ben Robert Dickie
Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics
François Goehringer, Alexandra Bruyere, Matthieu Doyen, Sibylle Bevilacqua, Alexandre Charmillon, Sebastien Heyer, Antoine Verger
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)
Francesco Lanfranchi, Dario Arnaldi, Alberto Miceli, Pietro Mattioli, Francesca D’Amico, Stefano Raffa, Maria Isabella Donegani, Silvia Chiola, Federico Massa, Matteo Pardini, Tania Di Raimondo, Gianmario Sambuceti, Matteo Bauckneht, Flavio Nobili, Silvia Morbelli
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies
Moath Said Alfawara, Ahmed Ibrahim Ahmed, Jean Michel Saad, Yushui Han, Fares Alahdab, Mahmoud Al Rifai, Mahwash Kassi, Talal Alnabelsi, William A. Zoghbi, Mouaz H. Al-Mallah
Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications
Zhongquan Cheng, Jiaojiao Ma, Lin Yin, Leyi Yu, Zhu Yuan, Bo Zhang, Jie Tian, Yang Du
[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients
Elin Pauwels, Sofie Celen, Kristof Baete, Michel Koole, Oliver Bechter, Marie Bex, Marleen Renard, Paul M. Clement, Sander Jentjens, Kim Serdons, Koen Van Laere, Guy Bormans, Christophe M. Deroose
[18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study
Atia Samim, Thomas Blom, Alex J. Poot, Albert D. Windhorst, Marta Fiocco, Nelleke Tolboom, Arthur J. A. T. Braat, Sebastiaan L. Meyer Viol, Rob van Rooij, Max M. van Noesel, Marnix G. E. H. Lam, Godelieve A. M. Tytgat, Bart de Keizer
Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma
Christos Sachpekidis, Leyun Pan, Annette Kopp-Schneider, Vivienn Weru, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss
Phantom-based evaluation of yttrium-90 datasets using biograph vision quadra
Konstantinos G. Zeimpekis, Lorenzo Mercolli, Maurizio Conti, Hasan Sari, George Prenosil, Kuangyu Shi, Axel Rominger
Glioblastoma PET/MRI: kinetic investigation of [18F]rhPSMA-7.3, [18F]FET and [18F]fluciclovine in an orthotopic mouse model of cancer
Marcel Lindemann, Ana Oteiza, Montserrat Martin-Armas, Yngve Guttormsen, Angel Moldes-Anaya, Rodrigo Berzaghi, Trond Velde Bogsrud, Tore Bach-Gansmo, Rune Sundset, Mathias Kranz
Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
Noémie S. Minczeles, Eelke M. Bos, Reinoud C. de Leeuw, Johan M. Kros, Mark W. Konijnenberg, Jacoline E. C. Bromberg, Wouter W. de Herder, Clemens M. F. Dirven, Johannes Hofland, Tessa Brabander
[18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT
Xingyu Mu, Xiaoxue Huang, Zewen Jiang, Meng Li, Lulu Jia, Zhongyuan Lv, Wei Fu, Jingsong Mao
[68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors’ density by immunochemistry techniques
Ankit Watts, Baljinder Singh, Harmandeep Singh, Amanjit Bal, Harneet Kaur, Ninjit Dhanota, Sunil K. Arora, Bhagwant R. Mittal, Digambar Behera
The role of [99mTc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience
Xi Jia, Xinru Li, Bing Jia, Ye Yang, Yuanbo Wang, Yan Liu, Ting Ji, Xin Xie, Yu Yao, Guanglin Qiu, Huixing Deng, Zhaohui Zhu, Si Chen, Aimin Yang, Rui Gao
Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study
Zhi-Bin Ke, Shao-Ming Chen, Jia-Yin Chen, Shao-Hao Chen, Qi You, Jiang-Bo Sun, Yu-Ting Xue, Xiong-Lin Sun, Xiao-Hui Wu, Qing-Shui Zheng, Yong Wei, Xue-Yi Xue, Ning Xu
Tumor lesion detection in patients with cervical cancer by indocyanine green near-infrared imaging
Pengfei Li, Jiaqi Liu, Kunshan He, Shipeng Gong, Chongwei Chi, Pan Liu, Guidong Su, Weili Li, Hui Duan, Ping Liu, Jie Tian, Chunlin Chen
Three-way multiplexing in prostate cancer patients — combining a bimodal sentinel node tracer with multicolor fluorescence imaging
Anne-Claire Berrens, Matthias N. van Oosterom, Leon J. Slof, Fijs W. B. van Leeuwen, Henk G. van der Poel, Tessa Buckle
Advanced imaging findings in stroke-like migraine attacks after radiation therapy (SMART) syndrome
Nico Teske, Nathalie L. Albert, Robert Forbrig, Nina C. Teske, Louisa von Baumgarten, Wolfgang G. Kunz, Joerg-Christian Tonn, Niklas Thon, Philipp Karschnia
[177Lu]Lu-FAP-2286 therapy in a case of right lung squamous cell carcinoma with systemic metastases
Zijuan Rao, Yu Zhang, Liyi Liu, Min Wang, Chunyin Zhang
Active uptake of [18F]F-FAPI-42 in eosinophilic gastrointestinal disorder
Lilan Fu, Wenlan Zhou
Neurexin-3α-associated autoimmune encephalitis with intracranial diffuse large B lymphoma diagnosed on FDG and TSPO PET/MRI
Chenpeng Zhang, Yong Hao, Hongda Shao, Mei Xin, Shuwei Bai, Yangtai Guan, Jianjun Liu
Correction to: Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects
Nicolas J. Guehl, Dustin W. Wooten, Daniel L. Yokell, Sung-Hyun Moon, Maeva Dhaynaut, Samantha Katz, Kirsten A. Moody, Codi Gharagouzloo, Aurélie Kas, Keith A. Johnson, Georges El Fakhri, Marc D. Normandin